Cargando…

Bile Acid Sequestrants Based on Natural and Synthetic Gels

Bile acid sequestrants (BASs) are non-systemic therapeutic agents used for the management of hypercholesterolemia. They are generally safe and not associated with serious systemic adverse effects. Usually, BASs are cationic polymeric gels that have the ability to bind bile salts in the small intesti...

Descripción completa

Detalles Bibliográficos
Autores principales: Stanciu, Magdalena-Cristina, Nichifor, Marieta, Teacă, Carmen-Alice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298123/
https://www.ncbi.nlm.nih.gov/pubmed/37367171
http://dx.doi.org/10.3390/gels9060500
_version_ 1785064038203392000
author Stanciu, Magdalena-Cristina
Nichifor, Marieta
Teacă, Carmen-Alice
author_facet Stanciu, Magdalena-Cristina
Nichifor, Marieta
Teacă, Carmen-Alice
author_sort Stanciu, Magdalena-Cristina
collection PubMed
description Bile acid sequestrants (BASs) are non-systemic therapeutic agents used for the management of hypercholesterolemia. They are generally safe and not associated with serious systemic adverse effects. Usually, BASs are cationic polymeric gels that have the ability to bind bile salts in the small intestine and eliminate them by excretion of the non-absorbable polymer–bile salt complex. This review gives a general presentation of bile acids and the characteristics and mechanisms of action of BASs. The chemical structures and methods of synthesis are shown for commercial BASs of first- (cholestyramine, colextran, and colestipol) and second-generation (colesevelam and colestilan) and potential BASs. The latter are based on either synthetic polymers such as poly((meth)acrylates/acrylamides), poly(alkylamines), poly(allylamines) and vinyl benzyl amino polymers or biopolymers, such as cellulose, dextran, pullulan, methylan, and poly(cyclodextrins). A separate section is dedicated to molecular imprinting polymers (MIPs) because of their great selectivity and affinity for the template molecules used in the imprinting technique. Focus is given to the understanding of the relationships between the chemical structure of these cross-linked polymers and their potential to bind bile salts. The synthetic pathways used in obtaining BASs and their in vitro and in vivo hypolipidemic activities are also introduced.
format Online
Article
Text
id pubmed-10298123
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102981232023-06-28 Bile Acid Sequestrants Based on Natural and Synthetic Gels Stanciu, Magdalena-Cristina Nichifor, Marieta Teacă, Carmen-Alice Gels Review Bile acid sequestrants (BASs) are non-systemic therapeutic agents used for the management of hypercholesterolemia. They are generally safe and not associated with serious systemic adverse effects. Usually, BASs are cationic polymeric gels that have the ability to bind bile salts in the small intestine and eliminate them by excretion of the non-absorbable polymer–bile salt complex. This review gives a general presentation of bile acids and the characteristics and mechanisms of action of BASs. The chemical structures and methods of synthesis are shown for commercial BASs of first- (cholestyramine, colextran, and colestipol) and second-generation (colesevelam and colestilan) and potential BASs. The latter are based on either synthetic polymers such as poly((meth)acrylates/acrylamides), poly(alkylamines), poly(allylamines) and vinyl benzyl amino polymers or biopolymers, such as cellulose, dextran, pullulan, methylan, and poly(cyclodextrins). A separate section is dedicated to molecular imprinting polymers (MIPs) because of their great selectivity and affinity for the template molecules used in the imprinting technique. Focus is given to the understanding of the relationships between the chemical structure of these cross-linked polymers and their potential to bind bile salts. The synthetic pathways used in obtaining BASs and their in vitro and in vivo hypolipidemic activities are also introduced. MDPI 2023-06-19 /pmc/articles/PMC10298123/ /pubmed/37367171 http://dx.doi.org/10.3390/gels9060500 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Stanciu, Magdalena-Cristina
Nichifor, Marieta
Teacă, Carmen-Alice
Bile Acid Sequestrants Based on Natural and Synthetic Gels
title Bile Acid Sequestrants Based on Natural and Synthetic Gels
title_full Bile Acid Sequestrants Based on Natural and Synthetic Gels
title_fullStr Bile Acid Sequestrants Based on Natural and Synthetic Gels
title_full_unstemmed Bile Acid Sequestrants Based on Natural and Synthetic Gels
title_short Bile Acid Sequestrants Based on Natural and Synthetic Gels
title_sort bile acid sequestrants based on natural and synthetic gels
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298123/
https://www.ncbi.nlm.nih.gov/pubmed/37367171
http://dx.doi.org/10.3390/gels9060500
work_keys_str_mv AT stanciumagdalenacristina bileacidsequestrantsbasedonnaturalandsyntheticgels
AT nichiformarieta bileacidsequestrantsbasedonnaturalandsyntheticgels
AT teacacarmenalice bileacidsequestrantsbasedonnaturalandsyntheticgels